Literature DB >> 10417132

Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells.

G E Wood1, S M Dutro, P A Totten.   

Abstract

Haemophilus ducreyi, the causative agent of chancroid, produces a hemolysin, whose role in virulence is not well defined. To assess the possible role of hemolysin in pathogenesis, we evaluated its target cell range by using wild-type H. ducreyi 35000, nonhemolytic mutants with the hemolysin structural gene deleted, and isogenic strains expressing different amounts of hemolytic activity. The cytotoxicity of the various cell types was assessed by quantitating the release of lactate dehydrogenase into culture supernatants as a measure of cell lysis. In these experiments, human foreskin fibroblasts, human foreskin epithelial cells, and, to a lesser extent, HEp-2 cells were lysed by H. ducreyi hemolysin. Hemolysin also lysed human blood mononuclear cells and immune system cell lines including U937 macrophage-like cells, T lymphocytes, and B lymphocytes. In contrast, human polymorphonuclear leukocytes were not sensitive to hemolysin under the conditions tested. We also analyzed the effect of hemolysin on invasion of human epithelial cells and found that H. ducreyi strains expressing cloned hemolysin genes showed a 10-fold increase in invasion compared to the control strain. These data support the hypothesis that the H. ducreyi hemolysin is important in the pathogenesis of chancroid and may contribute to ulcer formation, invasion of epithelial cells, and evasion of the immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417132      PMCID: PMC96648     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Haemophilus ducreyi, a cytotoxin-producing bacterium.

Authors:  M Purvén; T Lagergård
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Use of electroporation to construct isogenic mutants of Haemophilus ducreyi.

Authors:  E J Hansen; J L Latimer; S E Thomas; M Helminen; W L Albritton; J D Radolf
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Clear broth and plate media for culture of Haemophilus ducreyi.

Authors:  P A Totten; W E Stamm
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

4.  Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci.

Authors:  N Ruiz; B Wang; A Pentland; M Caparon
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

5.  Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men.

Authors:  D W Cameron; J N Simonsen; L J D'Costa; A R Ronald; G M Maitha; M N Gakinya; M Cheang; J O Ndinya-Achola; P Piot; R C Brunham
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

6.  Molecular characterization of the hemolysin determinant of Serratia marcescens.

Authors:  K Poole; E Schiebel; V Braun
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

7.  Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection.

Authors:  K L Palmer; A C Thornton; K R Fortney; A F Hood; R S Munson; S M Spinola
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

8.  Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi.

Authors:  P J Willson; W L Albritton; L Slaney; J K Setlow
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Identification of a hemolytic activity elaborated by Haemophilus ducreyi.

Authors:  K L Palmer; S Grass; R S Munson
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  A diffusible cytotoxin of Haemophilus ducreyi.

Authors:  L D Cope; S Lumbley; J L Latimer; J Klesney-Tait; M K Stevens; L S Johnson; M Purven; R S Munson; T Lagergard; J D Radolf; E J Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

View more
  32 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi.

Authors:  Isabelle Leduc; C Dinitra White; Igor Nepluev; Robert E Throm; Stanley M Spinola; Christopher Elkins
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

7.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

8.  Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.

Authors:  Sherri D Rinker; Michael P Trombley; Xiaoping Gu; Kate R Fortney; Margaret E Bauer
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

9.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Authors:  Kristy L B Mount; Carisa A Townsend; Sherri D Rinker; Xiaoping Gu; Kate R Fortney; Beth W Zwickl; Diane M Janowicz; Stanley M Spinola; Barry P Katz; Margaret E Bauer
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.